News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
780,912 Results
Type
Article (30407)
Company Profile (13)
Press Release (750492)
Multimedia
Podcasts (115)
Webinars (14)
Section
Business (263233)
Career Advice (3987)
Deals (39281)
Drug Delivery (169)
Drug Development (88468)
Employer Resources (192)
FDA (18511)
Job Trends (16835)
News (389818)
Policy (37618)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (2980)
Accelerated approval (35)
ADA (10)
Adcomms (42)
Allergies (83)
Alliances (56103)
ALS (55)
Alzheimer's disease (1347)
Antibody-drug conjugate (ADC) (210)
Approvals (18217)
Artificial intelligence (182)
ASCO (125)
Autoimmune disease (179)
Automation (13)
Bankruptcy (387)
Best Places to Work (12250)
BIO (37)
Biologics (2)
BIOSECURE Act (13)
Biosimilars (110)
BioSpace Insights (112)
Biotechnology (9)
Bladder cancer (86)
Brain cancer (21)
Breast cancer (279)
Cancer (2268)
Cardiovascular disease (185)
Career advice (3409)
Career pathing (46)
CAR-T (215)
CDC (64)
CDMO (93)
Celiac Disease (1)
Cell therapy (429)
Cervical cancer (15)
Clinical research (71381)
Collaboration (445)
Commercialization (3)
Compensation (235)
Complete response letters (74)
COVID-19 (3028)
CRISPR (34)
C-suite (197)
Cystic fibrosis (91)
Data (2949)
Decentralized trials (2)
Denatured (44)
Depression (53)
Dermatology (69)
Diabetes (222)
Diagnostics (6633)
Digital health (17)
Diversity (6)
Diversity, equity & inclusion (48)
Drug discovery (80)
Drug pricing (165)
Drug shortages (27)
Duchenne muscular dystrophy (117)
Earnings (97859)
Editorial (48)
Employer branding (24)
Employer resources (166)
Events (127377)
Executive appointments (186)
FDA (19683)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (13)
Funding (380)
Gene editing (65)
Generative AI (22)
Gene therapy (239)
GLP-1 (737)
Government (5393)
Grass and pollen (5)
Guidances (303)
Healthcare (20665)
Hematology (71)
HIV (51)
Huntington's disease (23)
IgA nephropathy (52)
Immunology and inflammation (111)
Immuno-oncology (37)
Indications (82)
Infectious disease (3225)
Inflammatory bowel disease (146)
Inflation Reduction Act (14)
Influenza (78)
Intellectual property (84)
Interviews (796)
IPO (17431)
IRA (54)
Job creations (4733)
Job search strategy (2703)
JPM (25)
Kidney cancer (16)
Labor market (46)
Layoffs (508)
Leadership (44)
Legal (9487)
Licensing (5)
Liver cancer (80)
Longevity (6)
Lung cancer (341)
Lymphoma (293)
Machine learning (8)
Management (65)
Manufacturing (347)
Marketing (4)
MASH (66)
Medical device (14200)
Medtech (14250)
Mergers & acquisitions (21858)
Metabolic disorders (665)
mRNA (210)
Multiple sclerosis (90)
NASH (18)
Neurodegenerative disease (107)
Neuropsychiatric disorders (28)
Neuroscience (1811)
NextGen: Class of 2026 (7247)
Non-profit (5045)
Now hiring (38)
Obesity (369)
Opinion (324)
Ovarian cancer (92)
Pain (68)
Pancreatic cancer (105)
Parkinson's disease (94)
Partnered (15)
Patents (195)
Patient recruitment (123)
Peanut (43)
People (63630)
Pharmaceutical (7)
Pharmacy benefit managers (22)
Phase 1 (21974)
Phase 2 (31169)
Phase 3 (23781)
Pipeline (4266)
Policy (295)
Postmarket research (2907)
Preclinical (9285)
Press Release (72)
Prostate cancer (110)
Psychedelics (34)
Radiopharmaceuticals (229)
Rare diseases (518)
Real estate (7080)
Recruiting (74)
Regulatory (25444)
Reports (40)
Research institute (2649)
Resumes & cover letters (634)
Rett syndrome (9)
RNA editing (8)
RSV (57)
Schizophrenia (56)
Series A (57)
Series B (39)
Service/supplier (1)
Sickle cell disease (42)
Special edition (14)
Spinal muscular atrophy (157)
Sponsored (34)
Startups (4163)
State (1)
Stomach cancer (13)
Supply chain (43)
Tariffs (47)
The Weekly (70)
Vaccines (972)
Venture capital (31)
Weight loss (280)
Women's health (47)
Worklife (23)
Date
Today (24)
Last 7 days (87)
Last 30 days (599)
Last 365 days (8601)
2026 (5714)
2025 (8910)
2024 (26309)
2023 (42561)
2022 (53926)
2021 (58719)
2020 (57662)
2019 (51334)
2018 (38957)
2017 (34568)
2016 (34810)
2015 (41098)
2014 (35994)
2013 (31852)
2012 (34001)
2011 (34209)
2010 (35433)
Location
Africa (870)
Alabama (44)
Alaska (6)
Arizona (243)
Arkansas (11)
Asia (45462)
Australia (7369)
California (4523)
Canada (1483)
China (525)
Colorado (203)
Connecticut (225)
Delaware (169)
Europe (102697)
Florida (593)
Georgia (151)
Hawaii (1)
Idaho (65)
Illinois (514)
India (39)
Indiana (288)
Iowa (2)
Japan (197)
Kansas (108)
Kentucky (15)
Louisiana (22)
Maine (61)
Maryland (649)
Massachusetts (3358)
Michigan (170)
Minnesota (351)
Mississippi (1)
Missouri (38)
Montana (24)
Nebraska (22)
Nevada (38)
New Hampshire (59)
New Jersey (1599)
New Mexico (19)
New York (1304)
North Carolina (871)
North Dakota (7)
Northern California (2391)
Ohio (161)
Oklahoma (9)
Oregon (30)
Pennsylvania (1052)
Puerto Rico (4)
Rhode Island (11)
South America (1300)
South Carolina (17)
Southern California (1847)
Tennessee (41)
Texas (607)
United States (17877)
Utah (123)
Vermont (1)
Virginia (61)
Washington D.C. (24)
Washington State (443)
West Virginia (3)
Wisconsin (33)
780,912 Results for "19".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Pharma manufacturing projected to create 19,000 jobs through 2034
The forecast makes pharma one of the fastest-growing manufacturing industries in the U.S.
June 3, 2026
·
2 min read
·
Nick Paul Taylor
COVID-19
FDA assembles vaccine experts to update COVID-19 formulation
The FDA will convene its vaccines advisory panel to discuss seasonal COVID-19 vaccines—a surprise move after Health Secretary and vaccine skeptic Robert F. Kennedy, Jr. overhauled a separate vaccine committee.
May 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Regeneron Announces Investor Conference Presentations - August 19, 2026
August 19, 2026
·
1 min read
Press Releases
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
September 9, 2026
·
5 min read
RNA editing
Lilly targets kidney disease with Ascidian’s RNA exon editors for up to $1.9B
For an investment of up to $1.9 billion, Eli Lilly will be able to use Ascidian Therapeutics’ platform that removes mutated exons from mRNA molecules, avoiding the expression of disease-causing proteins.
June 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
JUVÉDERM® Day Returns to U.S. on August 19
July 30, 2026
·
11 min read
Vaccines
Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment
COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Moderna is apparently also facing enrollment challenges.
April 2, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to treat severe swelling episodes caused by the rare genetic disorder hereditary angioedema.
April 29, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
August 27, 2026
·
7 min read
Earnings
BioNTech cuts sales forecast on slumping demand for COVID-19 vaccine
Lower vaccine demand across every market and more acute pressures in Germany led BioNTech to lower the midpoint of its sales outlook by almost 20%.
August 4, 2026
·
2 min read
·
Nick Paul Taylor
1 of 78,092
Next
